Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

These researchers from McGill University are using waste could potentially expand how and where low-carbon hydrogen can be ...

IgA nephropathy is a type of kidney disease that is typically treated with various medicines and lifestyle changes. Learn more about IgA nephropathy treatment here.

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious ...

"These findings suggest that consciously generated positive expectations can engage reward circuitry to influence immune ...

Johnson Matthey has opened a US$3.1m hydrogen internal combustion engine facility in Gothenburg to test emission control ...

Reinventy Solutions Corp. announced an advance in its materials-driven technology roadmap, highlighting XHT™ (eXtended High-Temperature) material architectures and Phantom Core™ electric system ...

Businesses play a critical role in building a new, integrated system of learning and work because they see change first. They ...

The University of Hawaii John A. Burns School of Medicine has been selected as one of 11 medical schools nationwide to ...

Explore how blood pressure drugs can be influenced by beige fat and its role in regulating hypertension and vascular health.

Maryland's Whole Watershed Program is advancing with $11.2 million in state funding for 37 projects across five selected ...